KA
NKTR icon

Klingman & Associates’s Nektar Therapeutics NKTR Stock Holding History

Klingman & Associates’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,338
Closed -$79.2K – 202
2022
Q4 		$79.2K Sell
2,338
-34
-1% -$1.15K 0.01% 202
2022
Q3 		$114K Buy
+2,372
New +$114K 0.01% 185